214 related articles for article (PubMed ID: 9368819)
1. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P
Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
[TBL] [Abstract][Full Text] [Related]
2. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men.
Hoffstedt J; Arner P; Hellers G; Lönnqvist F
J Lipid Res; 1997 Apr; 38(4):795-804. PubMed ID: 9144094
[TBL] [Abstract][Full Text] [Related]
3. Determination of beta 3-adrenoceptor mediated lipolysis in human fat cells.
Hoffstedt J; Shimizu M; Sjöstedt S; Lönnqvist F
Obes Res; 1995 Sep; 3(5):447-57. PubMed ID: 8521164
[TBL] [Abstract][Full Text] [Related]
4. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
[TBL] [Abstract][Full Text] [Related]
5. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
[TBL] [Abstract][Full Text] [Related]
6. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives.
Hellström L; Langin D; Reynisdottir S; Dauzats M; Arner P
Diabetologia; 1996 Aug; 39(8):921-8. PubMed ID: 8858214
[TBL] [Abstract][Full Text] [Related]
8. Agonist and antagonist properties of beta 3-adrenoceptors in human omental and mouse 3T3-L1 adipocytes.
Shimizu M; Blaak EE; Lonnqvist F; Gafvels ME; Arner P
Pharmacol Toxicol; 1996 Apr; 78(4):254-63. PubMed ID: 8861784
[TBL] [Abstract][Full Text] [Related]
9. Effect of CL316,243, a highly specific beta(3)-adrenoceptor agonist, on lipolysis of epididymal, mesenteric and subcutaneous adipocytes in rats.
Umekawa T; Yoshida T; Sakane N; Kondo M
Endocr J; 1997 Feb; 44(1):181-5. PubMed ID: 9152632
[TBL] [Abstract][Full Text] [Related]
10. Lipolysis in human fat cells obtained under local and general anesthesia.
Large V; Reynisdottir S; Eleborg L; van Harmelen V; Strömmer L; Arner P
Int J Obes Relat Metab Disord; 1997 Jan; 21(1):78-82. PubMed ID: 9023606
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells.
Hellmér J; Marcus C; Sonnenfeld T; Arner P
J Clin Endocrinol Metab; 1992 Jul; 75(1):15-20. PubMed ID: 1320047
[TBL] [Abstract][Full Text] [Related]
12. Effects of several putative beta 3-adrenoceptor agonists on lipolysis in human omental adipocytes.
Hoffstedt J; Lönnqvist F; Shimizu M; Blaak E; Arner P
Int J Obes Relat Metab Disord; 1996 May; 20(5):428-34. PubMed ID: 8696421
[TBL] [Abstract][Full Text] [Related]
13. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
Barbe P; Millet L; Galitzky J; Lafontan M; Berlan M
Br J Pharmacol; 1996 Mar; 117(5):907-13. PubMed ID: 8851509
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a functional beta 3-adrenoceptor in man.
Lönnqvist F; Krief S; Strosberg AD; Nyberg S; Emorine LJ; Arner P
Br J Pharmacol; 1993 Nov; 110(3):929-36. PubMed ID: 7905344
[TBL] [Abstract][Full Text] [Related]
15. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.
Hellström L; Wahrenberg H; Reynisdottir S; Arner P
J Clin Endocrinol Metab; 1997 Jan; 82(1):159-66. PubMed ID: 8989252
[TBL] [Abstract][Full Text] [Related]
16. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
[TBL] [Abstract][Full Text] [Related]
17. Lipolytic effects of conventional beta 3-adrenoceptor agonists and of CGP 12,177 in rat and human fat cells: preliminary pharmacological evidence for a putative beta 4-adrenoceptor.
Galitzky J; Langin D; Verwaerde P; Montastruc JL; Lafontan M; Berlan M
Br J Pharmacol; 1997 Nov; 122(6):1244-50. PubMed ID: 9401793
[TBL] [Abstract][Full Text] [Related]
18. The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis.
Rydén M; Hoffstedt J; Eriksson P; Bringman S; Arner P
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1599-603. PubMed ID: 11753577
[TBL] [Abstract][Full Text] [Related]
19. Alpha 2A-adrenergic regulation of cyclic AMP accumulation and lipolysis in human omental and subcutaneous adipocytes.
Vikman HL; Savola JM; Raasmaja A; Ohisalo JJ
Int J Obes Relat Metab Disord; 1996 Feb; 20(2):185-9. PubMed ID: 8646256
[TBL] [Abstract][Full Text] [Related]
20. Lipolytic and nutritive blood flow response to beta-adrenoceptor stimulation in situ in subcutaneous abdominal adipose tissue in obese men.
Schiffelers SL; Akkermans JA; Saris WH; Blaak EE
Int J Obes Relat Metab Disord; 2003 Feb; 27(2):227-31. PubMed ID: 12587003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
